CPC C07K 16/2896 (2013.01) [A61P 35/00 (2018.01); C12N 15/1138 (2013.01); C07K 2317/55 (2013.01)] | 10 Claims |
1. A method for treating cancer in a subject, comprising:
administering, to the subject, a pharmaceutical composition,
wherein the pharmaceutical composition comprises a substance that binds to LRIT2 protein as an active ingredient,
wherein the substance that binds to LRIT2 protein is a neutralizing antibody or a fragment thereof which specifically binds to the LRIT2 protein.
|